Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib in chronic hepatitis D
NCT01495585Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Dec 2011
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
A Phase 2 trial of lonafarnib in hepatitis D (HDV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Dec 2011; status: completed.
02
Drugs
lonafarnib
03
Conditions
hepatitis D (HDV)
Beyond the preview
Go deeper on NCT01495585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495585.